Synergistic effects of troglitazone and oleate on the translatability of preproinsulin mRNA from INS-1 cells

Biochemical Pharmacology

Volumn 64, Issue 11, 2002, Pages 1629-1636

  Bollheimer, L Cornelius ^a   Kagerbauer, Simone M ^a   Buettner, Roland ^a   Kemptner, Daniela M ^a   Palitzsch, Klaus Dieter ^a   Schölmerich, Jürgen ^a   Hügl, Sigrun R ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Free fatty acids; Glitazones; In vitro translation; INS 1 cells; Insulin biosynthesis; Pancreatic cells; Thiazolidinediones; Troglitazone

Indexed keywords

GLUCOSE; MESSENGER RNA; OLEIC ACID; OXYGEN; PREPROINSULIN; TROGLITAZONE;

ARTICLE; CELL LEVEL; CELL LINE; CYTOLYSIS; CYTOPLASM; DRUG EFFECT; DRUG EXPOSURE; DRUG POTENTIATION; INCUBATION TIME; INSULIN SYNTHESIS; MESSENGER RNA SYNTHESIS; NORTHERN BLOTTING; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RNA ANALYSIS; RNA EXTRACTION; RNA TRANSLATION;

ANIMALS; CELL LINE; CHROMANS; DRUG SYNERGISM; INSULIN; OLEIC ACID; PROINSULIN; PROTEIN BIOSYNTHESIS; PROTEIN PRECURSORS; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; THIAZOLES; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS;

EID: 0036890368     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)01352-7     Document Type: Article

References (50)

1. Wolffenbuttel B.H., Gomis R., Squatrito S., Jones N.P., Patwardhan R.N. Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients. Diabet. Med. 17:2000;40-47.
2. Gillies P.S., Dunn C.J. Pioglitazone. Drugs. 60:2000;333-343.
3. Horton E.S., Whitehouse F., Ghazzi M.N., Venable T.C., Whitcomb R.W. Troglitazone in combination with sulfonylurea restores glycemic control in patients with type 2 diabetes. Diabetes Care. 21:1998;1462-1469.
4. Kumar S., Boulton A.J., Beck-Nielsen H., Berthezene F., Muggeo M., Persson B., Spinas G.A., Donoghue S., Lettis S., Stewart-Long P. Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Diabetologia. 39:1996;701-709.
5. Matthaei S., Stummvoll M., Kellerer M., Haring H.U. Pathophysiology and pharmacological treatment of insulin resistance. Endocr. Rev. 21:2001;585-619.
6. Rocchi S., Auwerx J. Peroxisome proliferator-activated receptor-gamma: a versatile metabolic regulator. Ann. Med. 31:1999;342-351.
7. Sunayama S., Watanabe Y., Daida H., Yamaguchi H. Thiazolidinediones, dyslipidaemia and insulin resistance syndrome. Curr. Opin. Lipidol. 11:2000;397-402.
8. Olefsky J.M., Saltiel A.R. PPARgamma and the treatment of insulin resistance. Trends Endocrinol. Metab. 11:2000;362-368.
9. Reginato M.J., Lazar M.A. Mechanisms by which thiazolidinediones enhance insulin action. Trends Endocrinol. Metab. 10:1999;9-13.
10. Zhou Y.T., Shimabukuro M., Wang M.Y., Lee Y., Higa M., Milburn J.L., Newgard C.B., Unger R.H. Role of peroxisome proliferator-activated receptor alpha in disease of pancreatic beta cells. Proc. Natl. Acad. Sci. U.S.A. 95:1998;8898-8903.
11. Dubois M., Pattou F., Kerr-Conte J., Gmyr V., Vandewalle B., Desreumaux P., Auwerx J., Schoonjans K., Lefebvre J. Expression of peroxisome proliferator-activated receptor gamma (PPAR-gamma) in normal human pancreatic islet cells. Diabetologia. 43:2000;1165-1169.
12. Zhou Y.P., Grill V.E. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J. Clin. Invest. 93:1994;870-876.
13. Unger R.H. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes. 44:1995;863-870.
14. Bollheimer L.C., Skelly R.H., Chester M.W., McGarry J.D., Rhodes C.J. Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. J. Clin. Invest. 101:1998;1094-1101.
15. Cousin S.P., Hugl S.R., Wrede C.E., Kajio H., Myers M.G. Jr., Rhodes C.J. Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic beta-cell line INS-1. Endocrinology. 142:2001;229-240.
16. Maedler K., Spinas G.A., Dyntar D., Moritz W., Kaiser N., Donath M.Y. Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function. Diabetes. 50:2001;69-76.
17. Shimabukuro M., Zhou Y.T., Lee Y., Unger R.H. Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats. J. Biol. Chem. 273:1998;3547-3550.
18. Higa M., Zhou Y.T., Ravazzola M., Baetens D., Orci L., Unger R.H. Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats. Proc. Natl. Acad. Sci. U.S.A. 96:1999;11513-11518.
19. Kawai T., Hirose H., Seto Y., Fujita H., Fujita H., Ukeda K., Saruta T. Troglitazone ameliorates lipotoxicity in the beta cell line INS-1 expressing PPAR gamma. Diabetes Res. Clin. Pract. 56:2002;83-92.
20. Cnop M., Hannaert J.C., Pipeleers D.G. Troglitazone does not protect rat pancreatic β cells against free fatty acid-induced cytotoxicity. Biochem. Pharmacol. 63:2002;1281-1285.
21. Elks M.L. Chronic perifusion of rat islets with palmitate suppresses glucose-stimulated insulin release. Endocrinology. 133:1993;208-214.
22. Gremlich S., Bonny C., Waeber G., Thorens B. Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels. J. Biol. Chem. 272:1997;30261-30269.
23. Ritz-Laser B., Meda P., Constant I., Klages N., Charollais A., Morales A., Magnan C., Ktorza A., Philippe J. Glucose-induced preproinsulin gene expression is inhibited by the free fatty acid palmitate. Endocrinology. 140:1999;4005-4014.
24. Asfari M., Janjic D., Meda P., Li G., Halban P.A., Wollheim C.B. Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology. 130:1992;167-178.
25. Goodge K.A., Hutton J.C. Translational regulation of proinsulin biosynthesis and proinsulin conversion in the pancreatic beta-cell. Semin. Cell Dev. Biol. 11:2000;235-242.
26. Wicksteed B., Herbert T.P., Alarcon C., Lingohr M.K., Moss L.G., Rhodes C.J. Co-operativity between the preproinsulin mRNA UTRs is necessary for glucose stimulated translation. J. Biol. Chem. 276:2001;22553-22558.
27. Itoh N., Okamoto H. Translational control of proinsulin synthesis by glucose. Nature. 283:1980;100-102.
28. Bollheimer L.C., Kestler T.M., Michel J., Buettner R., Scholmerich J., Palitzsch K.D. Intracellular depletion of insulin by oleate is due to an inhibited synthesis and not to an increased secretion. Biochem. Biophys. Res. Commun. 287:2001;397-401.
29. Skelly R.H., Bollheimer L.C., Wicksteed B.L., Corkey B.E., Rhodes C.J. A distinct difference in the metabolic stimulus-response coupling pathways for regulating proinsulin biosynthesis and insulin secretion that lies at the level of a requirement for fatty acyl moieties. Biochem. J. 331:1998;553-561.
30. Gough N.M. Rapid and quantitative preparation of cytoplasmic RNA from small numbers of cells. Anal. Biochem. 173:1988;93-95.
31. Schuppin G.T., Rhodes C.J. Specific coordinated regulation of PC2 and PC3 gene transcription with that of preproinsulin in insulin producing βTC3 cells. Biochem. J. 313:1995;259-268.
32. Olliver L., Boyd C.D. In vitro translation of messenger RNA in a rabbit reticulocyte lysate cell-free system. Methods Mol. Biol. 86:1998;221-227.
33. Sankoh A.J., Huque M.F., Dubey S.D. Some comments on frequently used multiple endpoint adjustment methods in clinical trials. Statist. Med. 16:1997;2529-2542.
34. Lomedico P., Rosenthal N., Efstratidadis A., Gilbert W., Kolodner R., Tizard R. The structure and evolution of the two nonallelic rat preproinsulin genes. Cell. 18:1979;545-558.
35. McGarry J.D. What if Minkowski had been ageusic? An alternative angle on diabetes. Science. 258:1992;766-770.
36. Corkey B.E., Deeney J.T., Yaney G.C., Tornheim K., Prentki M. The role of long-chain fatty acyl-CoA esters in beta-cell signal transduction. J. Nutr. 130:2000;299S-304S.
37. Furukawa H., Carroll R.J., Swift H.H., Steiner D.F. Long-term elevation of free fatty acids leads to delayed processing of proinsulin and prohormone convertases 2 and 3 in the pancreatic beta-cell line MIN6. Diabetes. 48:1999;1395-1401.
38. Bjorklund A., Grill V. Enhancing effects of long-term elevated glucose and palmitate on stored and secreted proinsulin-to-insulin ratios in human pancreatic islets. Diabetes. 48:1999;1409-1414.
39. Sako Y., Grill V.E. A 48-hr lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology. 127:1990;1580-1589.
40. Deeney J.T., Gromada J., Hoy M., Olsen H.L., Rhodes C.J., Prentki M., Berggren P.O., Corkey B.E. Acute stimulation with long chain acyl-CoA enhances exocytosis in insulin-secreting cells (HIT T-15 and NMRI beta-cells). J. Biol. Chem. 275:2000;9363-9368.
41. Briaud I., Harmon J.S., Kelpe C.L., Segu V.B., Poitout V. Lipotoxicity of the pancreatic beta-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids. Diabetes. 50:2001;315-321.
42. Milburn J.L. Jr., Hirose H., Lee Y.H., Nagasawa Y., Ogawa A., Ohneda M., BeltrandelRio H., Newgard C.B., Johnson J.H., Unger R.H. Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. J. Biol. Chem. 270:1995;1295-1299.
43. Shimabukuro M., Zhou Y.T., Levi M., Unger R.H. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc. Natl. Acad. Sci. U.S.A. 95:1998;2498-2502.
44. Escher P., Wahli W. Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat. Res. 448:2000;121-138.
45. Murphy G.J., Holder J.C. PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer. Trends Pharmacol. Sci. 21:2000;469-474.
46. Chan S.J., Noyes B.E., Agarwal K.L., Steiner D.F. Construction and selection of recombinant plasmids containing full-length complementary DNAs corresponding to rat insulins I and II. Proc. Natl. Acad. Sci. U.S.A. 76:1979;5036-5040.
47. Cordell B., Diamond D., Smith S., Punter J., Schone H.H., Goodman H.M. Disproportionate expression of the two nonallelic rat insulin genes in a pancreatic tumor is due to translational control. Cell. 31:1982;531-542.
48. Jacobson A., Peltz S.W. Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells. Annu. Rev. Biochem. 65:1996;693-739.
49. Richieri G.V., Ogata R.T., Kleinfeld A.M. The measurement of free fatty acid concentration with the fluorescent probe ADIFAB: a practical guide for the use of the ADIFAB probe. Mol. Cell. Biochem. 192:1999;87-94.
50. Shibukawa A., Sawanda T., Nakao C., Izumi T., Nakagawa T. High-performance frontal analysis for the study of protein binding of troglitazone (CS-o45) in albumin solution and in human plasma. J. Chromatogr. A. 697:1995;337-343.